AMA calls for deferral of endorsement for pharmacist prescribers

Plans to enable pharmacists to autonomously prescribe Schedule 4 and S8 medicines jeopardises patient safety, the AMA warns  Moves to implement an endorsement for pharmacists to prescribe independently should be put on hold “in the absence of a robust, evidence-based, cost-risk-benefit analysis, the Australian Medical Association (AMA) says.  In its submission to the Australian Pharmacy Council’s (APC’s)